Insider Transactions last 24 months for Travere Therapeutics, Inc.  -  NSDQ: TVTX

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Reed Elizabeth EChief Legal Officer and GC03/16/2026DSDirectCOM10,000$28.09$280,861.00105,211
Reed Elizabeth EChief Legal Officer and GC03/16/2026AMDirectCOM10,000$19.08$190,800.00115,211
Dube Eric MCHIEF EXECUTIVE OFFICER02/20/2026DSDirectCOM60,000$30.10$1,805,766.00432,886
Dube Eric MCHIEF EXECUTIVE OFFICER02/20/2026AMDirectCOM60,000$15.46$927,600.00492,886
Reed Elizabeth EChief Legal Officer and GC02/17/2026DSDirectCOM4,321$28.26$122,120.10105,211
Reed Elizabeth EChief Legal Officer and GC02/17/2026DSDirectCOM5,679$27.50$156,195.22109,532
Reed Elizabeth EChief Legal Officer and GC02/17/2026AMDirectCOM10,000$19.08$190,800.00115,211
Reed Elizabeth EChief Legal Officer and GC02/04/2026DSDirectCOM509$32.74$16,664.66105,211
Reed Elizabeth EChief Legal Officer and GC02/04/2026DSDirectCOM2,485$32.07$79,693.95105,720
Inrig JulaCHIEF MEDICAL OFFICER02/04/2026DSDirectCOM232$32.85$7,621.20105,706
Inrig JulaCHIEF MEDICAL OFFICER02/04/2026DSDirectCOM1,547$32.11$49,674.17105,938
Cline Christopher R.CHIEF FINANCIAL OFFICER02/04/2026DSDirectCOM110$32.90$3,619.00111,226
Cline Christopher R.CHIEF FINANCIAL OFFICER02/04/2026DSDirectCOM1,635$32.14$52,548.90111,336
Reed Elizabeth EChief Legal Officer and GC02/03/2026DSDirectCOM7,175$32.12$230,461.00108,205
Rote William E.Chief Research Officer02/03/2026DSDirectCOM12,446$32.87$409,100.02109,087
Dube Eric MCHIEF EXECUTIVE OFFICER02/03/2026DSDirectCOM33,635$32.70$1,099,864.50432,886
Dube Eric MCHIEF EXECUTIVE OFFICER02/03/2026DSDirectCOM66,452$32.06$2,130,451.12466,521
Heerma PeterCHIEF COMMERCIAL OFFICER02/03/2026DSDirectCOM7,310$32.12$234,797.20131,823
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER02/03/2026DSDirectCOM4,333$32.12$139,175.9649,080
Inrig JulaCHIEF MEDICAL OFFICER02/03/2026DSDirectCOM6,956$32.12$223,426.72107,485
Cline Christopher R.CHIEF FINANCIAL OFFICER02/03/2026DSDirectCOM7,242$32.12$232,613.04112,971
Reed Elizabeth EChief Legal Officer and GC01/31/2026AADirectCOM25,110$0.00$0.00115,380
Rote William E.Chief Research Officer01/31/2026AADirectCOM20,090$0.00$0.00121,533
Dube Eric MCHIEF EXECUTIVE OFFICER01/31/2026AADirectCOM113,800$0.00$0.00532,973
Heerma PeterCHIEF COMMERCIAL OFFICER01/31/2026AADirectCOM26,120$0.00$0.00139,133
1   2  3  4  5  6  7  Next Last  You are at page 1 of 7 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust
Export Table Data to Excel Send to Excel